Alternative approaches to the prevention of coronary in-stent restenosis
Cardiovascular disease (CVD) has become the most common cause of mortality worldwide, accounting for approximately 30% of all deaths. The primary pathological process that underlies it is atherosclerosis. Atherosclerosis leads to the development of flow-limiting lesions that accumulate over years to...
Main Author: | Robertson, Keith Euan |
---|---|
Published: |
University of Glasgow
2014
|
Subjects: | |
Online Access: | http://ethos.bl.uk/OrderDetails.do?uin=uk.bl.ethos.616390 |
Similar Items
-
The Virtual International Stroke Trials Archive (VISTA) : promulgation of a clinical trial resource
by: Ali, Myzoon
Published: (2008) -
Validation of first pass magnetic resonance myocardial perfusion imaging using fractional flow reserve
by: Watkins, Stuart
Published: (2009) -
The role of microRNA 21 in the development of in-stent restenosis
by: Halliday, Crawford Alasdair
Published: (2015) -
The SSTARS (STeroids and stents Against Re-Stenosis) Trial : different stent alloys and the use of peri-procedural oral corticosteroids to prevent in-segment restenosis
by: Adam, Zulfiquar
Published: (2016) -
CD56+ T-cells in relation to cytomegalovirus in healthy subjects and kidney transplant patients
by: Almehmadi, Mazen
Published: (2014)